The Answer Page>Medical Education Library> New York State Practitioner Education Medical Use of Marijuana 2-hr Required Course > Section 3.0: The Use of Cannabis-based Products in Specific Patient Populations and Drug Interactions > Part 2 of 2
New York State Practitioner Education Medical Use of Marijuana 2-hr Required Course
You are not logged in. Only partial content from this topic will be available to you. To view the full content, you must log in to your account. Don't have a login? Register now. Or, check out our Preview.
Section 3.0: The Use of Cannabis-based Products in Specific Patient Populations and Drug Interactions
Part 2
Drug Interactions
Patients suffering from multiple sclerosis, chronic pain, cancer or AIDS often take several medications concurrently. In fact, sometimes cannabis and cannabinoid- based oral medicines (e.g. dronabinol, nabilone, nabiximols) are used as adjuvant therapy to alleviate some of the symptoms associated with these various chronic diseases. Presently, we will discuss the metabolism of cannabis and cannabinoid- based medicines. Also, we will address some of the potential drug interactions between cannabinoid medicines and therapeutic agents.
The cytochrome P450 enzymes are responsible for the metabolism of THC, cannabidiol (CBD) and cannabinol (CBN), the three main phytocannabinoids. Therefore, when cannabis therapy is combined with other drugs that are substrates, inducers, or inhibitors of the cytochrome P450 (CYP) family, cannabis drug interactions must be carefully monitored to avoid serious adverse reactions.
THC is oxidized by the CYP450 mixed-function oxidases CYP2C9, CYP2C19, and CYP3A4 (1). Cannabidiol (CBD) is also predicted to undergo significant metabolism via CYP isozymes 2C19 and 3A4 (2), and cannabinol (CBN) via CYP isozymes 2C9 and 3A4 (3-5). Cannabidiol and cannabinol may also be directly glucuronidated by several UGT isozymes (5, 6).
THC, CBD, and CBN are known to inhibit multiple CYP isozymes, including CYP1A1, 1A2, and 1B1. Medications such as amitryptiline, phenacetin and theophylline are metabolized by these isozymes and therefore the bioavailability of the above-mentioned drugs may be increased (7).